您是這個應用程式的開發人員嗎？驗證擁有權以管理此列表。
The Center for Drug Evaluation and Research (CDER) assesses bioequivalence (BE) in generic drug applications primarily through a combination of regulatory requirements, scientific guidelines, and statistical criteria. The process ensures that a generic drug performs in the same manner as its reference listed drug (RLD).
免責聲明：WebCatalog 與 Rhizome 並無任何隸屬、關聯、授權或認可關係，亦不以任何方式與其存在官方連結。所有產品名稱、標誌及品牌均為其各自所有者的財產。
